Mining Medline for the Treatment of Osteoporosis
| dc.contributor.author | Ceken, Cinar | |
| dc.contributor.author | Hassanpour, Reza | |
| dc.contributor.author | Esmelioglu, Sadik | |
| dc.contributor.author | Tolun, Mehmet Resit | |
| dc.contributor.author | Yildirim, Pinar | |
| dc.date.accessioned | 2020-04-07T17:26:49Z | |
| dc.date.accessioned | 2025-09-18T12:48:28Z | |
| dc.date.available | 2020-04-07T17:26:49Z | |
| dc.date.available | 2025-09-18T12:48:28Z | |
| dc.date.issued | 2012 | |
| dc.description | Tolun, Mehmet Resit/0000-0002-8478-7220; Yildirim, Pinar/0000-0003-3295-5699 | en_US |
| dc.description.abstract | In this paper, we consider the importance of osteoporosis disease in terms of medical research and pharmaceutical industry and we introduce a knowledge discovery approach regarding the treatment of osteoporosis from a historical perspective. Osteoporosis is a systemic skeletal disease in which osteoporotic fractures are associated with substantial morbidity and mortality and impaired quality of life. Osteoporosis has also higher costs, for example, longer hospital stays than many other diseases such as diabetes and heart attack and it is an attractive market for pharmaceutical companies. We use a freely available biomedical search engine leveraging text-mining technology to extract the drug names used in the treatment of osteoporosis from MEDLINE articles. We conclude that alendronate (Fosamax) and raloxifene (Evista) have the highest number of articles in MEDLINE and seem the dominating drugs for the treatment of osteoporosis in the last decade. | en_US |
| dc.identifier.citation | Yildirim, Pinar...et al. "Mining Medline for the Treatment of Osteoporosis", Journal of Medical Systems, Vol. 36, No. 4, pp. 2339-2347, (2012) | en_US |
| dc.identifier.doi | 10.1007/s10916-011-9701-6 | |
| dc.identifier.issn | 0148-5598 | |
| dc.identifier.issn | 1573-689X | |
| dc.identifier.scopus | 2-s2.0-84873030082 | |
| dc.identifier.uri | https://doi.org/10.1007/s10916-011-9701-6 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12416/12067 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.relation.ispartof | Journal of Medical Systems | |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Biomedical Text Mining | en_US |
| dc.subject | Osteoporosis | en_US |
| dc.subject | Information Extraction | en_US |
| dc.subject | Drug Therapy | en_US |
| dc.title | Mining Medline for the Treatment of Osteoporosis | en_US |
| dc.title | Mining Medlıne for the Treatment of Osteoporosis | tr_TR |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Tolun, Mehmet Resit/0000-0002-8478-7220 | |
| gdc.author.id | Yildirim, Pinar/0000-0003-3295-5699 | |
| gdc.author.scopusid | 6505872114 | |
| gdc.author.scopusid | 36476071800 | |
| gdc.author.scopusid | 56086374000 | |
| gdc.author.scopusid | 37080429000 | |
| gdc.author.scopusid | 6603446979 | |
| gdc.author.wosid | Yildirim, Pinar/X-1182-2019 | |
| gdc.author.wosid | Tolun, Mehmet Resit/Kcj-5958-2024 | |
| gdc.author.yokid | 101956 | |
| gdc.bip.impulseclass | C5 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C5 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | Çankaya University | en_US |
| gdc.description.departmenttemp | [Yildirim, Pinar; Hassanpour, Reza; Esmelioglu, Sadik; Tolun, Mehmet Resit] Cankaya Univ, Dept Comp Engn, Ankara, Turkey; [Ceken, Cinar] Turkey Antalya Educ & Res Hosp, Minist Hlth, Dept Phys Med & Rehabil, Antalya, Turkey | en_US |
| gdc.description.endpage | 2347 | en_US |
| gdc.description.issue | 4 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 2339 | en_US |
| gdc.description.volume | 36 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W2025977738 | |
| gdc.identifier.pmid | 21494854 | |
| gdc.identifier.wos | WOS:000306549000027 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 0.0 | |
| gdc.oaire.influence | 2.6067106E-9 | |
| gdc.oaire.isgreen | false | |
| gdc.oaire.keywords | Dose-Response Relationship, Drug | |
| gdc.oaire.keywords | Bibliometrics | |
| gdc.oaire.keywords | MEDLINE | |
| gdc.oaire.keywords | Data Mining | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | Osteoporosis | |
| gdc.oaire.keywords | United States | |
| gdc.oaire.popularity | 5.691068E-10 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 03 medical and health sciences | |
| gdc.oaire.sciencefields | 0302 clinical medicine | |
| gdc.openalex.collaboration | National | |
| gdc.openalex.fwci | 0.27952385 | |
| gdc.openalex.normalizedpercentile | 0.56 | |
| gdc.opencitations.count | 2 | |
| gdc.plumx.crossrefcites | 2 | |
| gdc.plumx.mendeley | 36 | |
| gdc.plumx.pubmedcites | 1 | |
| gdc.plumx.scopuscites | 3 | |
| gdc.publishedmonth | 8 | |
| gdc.scopus.citedcount | 3 | |
| gdc.virtual.author | Hassanpour, Reza | |
| gdc.virtual.author | Tolun, Mehmet Reşit | |
| gdc.wos.citedcount | 2 | |
| relation.isAuthorOfPublication | 9d0ac03c-117b-485a-b923-109829e41ba1 | |
| relation.isAuthorOfPublication | ee2f4db5-47a7-4796-a56a-611dc571a8ef | |
| relation.isAuthorOfPublication.latestForDiscovery | 9d0ac03c-117b-485a-b923-109829e41ba1 | |
| relation.isOrgUnitOfPublication | aef16c1d-5b84-42f9-9dab-8029b2b0befd | |
| relation.isOrgUnitOfPublication | 43797d4e-4177-4b74-bd9b-38623b8aeefa | |
| relation.isOrgUnitOfPublication | 0b9123e4-4136-493b-9ffd-be856af2cdb1 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | aef16c1d-5b84-42f9-9dab-8029b2b0befd |